Live feed07:01:00·22dPRReleasevia QuantisnowInvivyd Announces Completion of Enrollment in Upsized DECLARATION Clinical Trial, a Phase 3 Pivotal Study of VYD2311, an Investigational Antibody to Prevent COVIDByQuantisnow·Wall Street's wire, on your screen.IVVD· Invivyd Inc.Health Care
